Clinical Trials Directory

Trials / Completed

CompletedNCT00764010

Diet and Omega-3 Intervention Trial on Atherosclerosis

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
563 (actual)
Sponsor
Ullevaal University Hospital · Academic / Other
Sex
Male
Age
64 Years – 76 Years
Healthy volunteers
Not accepted

Summary

The study was actuated to evaluate the effects of a 3-year intervention with diet and/or very long chain omega-3 (VLC n-3 PUFA), in a randomized 2x2 factorial design on the progression of atherosclerosis in a high risk population. A total of 563 elderly men were included and randomized to receive usual care and VLC n-3 placebo capsules (control group), dietary advice and VLC n-3 placebo capsules, usual care and VLC n-3 capsules, and finally both VLC n-3 capsules and dietary advice. The evaluation of atherosclerosis were i) ultrasound measurement of carotid intima media thickening ii) pulse wave propagation time iii) circulating biomarkers of atherosclerosis.

Detailed description

The basis for recruitment was a follow up of subjects participating in the Oslo Diet and Anti Smoking Study (1972-1977) characterised as hypercholesterolemic in 1972. Measurements of the outcome variables were performed at baseline and after 36 m; blood sampling also after 6 and 18 m. In addition to the main outcome variables, a biobank was established for future analyses. Clinical events were also recorded.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNo dietary counseling and omega-3 capsulesOmega-3 2.4 g/day
DIETARY_SUPPLEMENTOmega-3 capsules and dietary counselingOmega-3 2.4 g/day and Mediterranean-like diet
DIETARY_SUPPLEMENTDietary counseling, placebo capsules for omega-3Mediterranean-like diet

Timeline

Start date
1997-05-01
Primary completion
2001-12-01
Completion
2001-12-01
First posted
2008-10-01
Last updated
2011-07-01

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00764010. Inclusion in this directory is not an endorsement.